‘This is the show which helps you make great pitches and presentations, so you can raise money, win business, and grow your confidence – and you’ll learn from people who are doing it at the highest level.
Although malaria no longer occurs in the Netherlands, the malaria mosquito and parasite flourish in TropIQ’s lab. They are being used to test new anti-malaria agents. Social enterprise TropIQ Health Sciences is also developing a very promising new agent. “It would be wonderful if this drug could save people’s lives,” says director Dr Koen Dechering.
Enzyre is developing an electronic microfluidic biochip to measure coagulation factor levels in minimum amounts of blood. The biochip is the size of a credit card and can easily fit into your pocket. Connecting this device to your smartphone will allow patients to comfortably and affordably measure your coagulation levels anywhere and at any time.
Tien jaar geleden investeerde ReumaNederland in het onderzoek van het Radboud Universitair Medisch Centrum naar nieuwe materialen voor protheses.
The synthetic meniscus prosthesis is intended for patients with knee osteoarthritis.
Tijdens deze uitzending vanuit de Health Valley studio, ging presentatrice Suzanne Verheijden in gesprek met diverse tafelgasten over hun…
You can now watch the recording of HVTV. Is prevention better than cure?
Samen met Tibor Bosse (Radboud Universiteit), Romy Blankendaal (TNO) en Eric Jutten (The Simulation Crew) bespreken we vragen als: wat…
Subject of this fifth episode: the use of AI in “virtual agents” to train people, for example to prepare them for certain work-related situations.
Breng ondernemers en onderzoekers bij elkaar, dan ontstaat er iets moois. Dat is de gedachte achter de Novio Tech Campus…
